Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jami Shaffer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Zebrafish|September 20, 2021
An Optimized Zebrafish Nursery Feeding Regimen Improves Growth Rates and Labor CostsToi A Collins, Shelby Cabrera, Emily Teets, et al.
Scientific Reports|February 9, 2020
Quantifying Hematopoietic Stem Cell Clonal Diversity by Selecting Informative Amplicon BarcodesEmily M Teets, Charles Gregory, Jami Shaffer, et al.
Molecular Cancer Research : MCR|November 28, 2023
Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine KinaseHimanshu Savardekar, Carter Allen, Hyeongseon Jeon, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
CD200 promotes immunosuppression in the pancreatic tumor microenvironmentFouad Choueiry, Molly Torok, Reena Shakya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2026
Single-Cell RNA-seq Analysis Reveals Distinct Tumor and Immunosuppressive T-Cell Phenotypes in Patients with CLL Treated with IbrutinibShanmugapriya Thangavadivel, Jami Shaffer, Shrilekha Misra, et al.
Cell Reports|May 20, 2023
Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase CVera Binder, Wantong Li, Muhammad Faisal, et al.
JCI Insight|November 8, 2024
Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumorsEmily Schwarz, Brooke Benner, Robert Wesolowski, et al.
Nature Communications|January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformationZachary A Hing, Janek S Walker, Ethan C Whipp, et al.
The Journal of Clinical Investigation|March 20, 2025
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environmentPu Zhang, Ethan C Whipp, Sarah J Skuli, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Zebrafish|September 20, 2021
An Optimized Zebrafish Nursery Feeding Regimen Improves Growth Rates and Labor CostsToi A Collins, Shelby Cabrera, Emily Teets, et al.
Scientific Reports|February 9, 2020
Quantifying Hematopoietic Stem Cell Clonal Diversity by Selecting Informative Amplicon BarcodesEmily M Teets, Charles Gregory, Jami Shaffer, et al.
Molecular Cancer Research : MCR|November 28, 2023
Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine KinaseHimanshu Savardekar, Carter Allen, Hyeongseon Jeon, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
CD200 promotes immunosuppression in the pancreatic tumor microenvironmentFouad Choueiry, Molly Torok, Reena Shakya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2026
Single-Cell RNA-seq Analysis Reveals Distinct Tumor and Immunosuppressive T-Cell Phenotypes in Patients with CLL Treated with IbrutinibShanmugapriya Thangavadivel, Jami Shaffer, Shrilekha Misra, et al.
Cell Reports|May 20, 2023
Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase CVera Binder, Wantong Li, Muhammad Faisal, et al.
JCI Insight|November 8, 2024
Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumorsEmily Schwarz, Brooke Benner, Robert Wesolowski, et al.
Nature Communications|January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformationZachary A Hing, Janek S Walker, Ethan C Whipp, et al.
The Journal of Clinical Investigation|March 20, 2025
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environmentPu Zhang, Ethan C Whipp, Sarah J Skuli, et al.
Pageof 1